CA3184333A1 - Compositions d'ions cuivre et methodes de traitement d'etats provoques par le coronavirus et la grippe - Google Patents

Compositions d'ions cuivre et methodes de traitement d'etats provoques par le coronavirus et la grippe

Info

Publication number
CA3184333A1
CA3184333A1 CA3184333A CA3184333A CA3184333A1 CA 3184333 A1 CA3184333 A1 CA 3184333A1 CA 3184333 A CA3184333 A CA 3184333A CA 3184333 A CA3184333 A CA 3184333A CA 3184333 A1 CA3184333 A1 CA 3184333A1
Authority
CA
Canada
Prior art keywords
copper ion
copper
subject
solution
cream
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3184333A
Other languages
English (en)
Inventor
Chunlim Abbott
Dominic C. Abbott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CDA Research Group Inc
Original Assignee
CDA Research Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/881,937 external-priority patent/US11000545B2/en
Application filed by CDA Research Group Inc filed Critical CDA Research Group Inc
Publication of CA3184333A1 publication Critical patent/CA3184333A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des formulations contenant des ions cuivre et des méthodes de traitement d'infections et d'états sous-jacents provoqués par le coronavirus, en particulier la COVID-19, et la grippe, en particulier la grippe A et/ou la grippe B à l'aide de telles formulations. Des méthodes de traitement des virus sous-jacents et de leurs conditions résultantes à l'aide de traitements topiques à base d'ions cuivre sont concernées. Un traitement topique sous sa forme basique comprend une solution ou une suspension d'ions cuivre biocompatible obtenue par extraction des ions cuivre à partir de cuivre métallique. La solution ou la suspension d'ions cuivre peut être combinée à divers supports pour former le traitement par ions cuivre comprenant des crèmes ou des solutions. L'invention concerne également des procédés de fabrication de la solution ou de la suspension d'ions cuivre à partir d'un métal de cuivre solide dans une solution biocompatible.
CA3184333A 2020-05-22 2021-03-29 Compositions d'ions cuivre et methodes de traitement d'etats provoques par le coronavirus et la grippe Pending CA3184333A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/881,937 2020-05-22
US16/881,937 US11000545B2 (en) 2013-03-15 2020-05-22 Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
PCT/US2021/024555 WO2021236231A1 (fr) 2020-05-22 2021-03-29 Compositions d'ions cuivre et méthodes de traitement d'états provoqués par le coronavirus et la grippe

Publications (1)

Publication Number Publication Date
CA3184333A1 true CA3184333A1 (fr) 2021-11-25

Family

ID=78708069

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3184333A Pending CA3184333A1 (fr) 2020-05-22 2021-03-29 Compositions d'ions cuivre et methodes de traitement d'etats provoques par le coronavirus et la grippe

Country Status (6)

Country Link
EP (1) EP4153193A4 (fr)
JP (1) JP2023526867A (fr)
KR (1) KR20230038422A (fr)
AU (1) AU2021274625A1 (fr)
CA (1) CA3184333A1 (fr)
WO (1) WO2021236231A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0602325D0 (en) * 2006-02-06 2006-03-15 Remedy Res Ltd Virucidal compositions and uses
US20070243263A1 (en) * 2006-04-14 2007-10-18 Agion Technologies, Inc. Antiviral Methods
US9549949B2 (en) * 2008-09-03 2017-01-24 Nbc Meshtec, Inc. Antiviral agent
US11007143B2 (en) * 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US11083750B2 (en) * 2013-03-15 2021-08-10 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11000545B2 (en) * 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
TW202206078A (zh) * 2020-04-28 2022-02-16 美商奧伊斯特普安生物製藥公司 局部投與菸鹼乙醯膽鹼受體促效劑用以抑制冠狀病毒感染

Also Published As

Publication number Publication date
WO2021236231A1 (fr) 2021-11-25
EP4153193A1 (fr) 2023-03-29
KR20230038422A (ko) 2023-03-20
JP2023526867A (ja) 2023-06-23
EP4153193A4 (fr) 2024-02-28
AU2021274625A1 (en) 2023-01-05

Similar Documents

Publication Publication Date Title
US11717535B2 (en) Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11857514B2 (en) Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US11253544B2 (en) Methods of treatment using topical copper ion formulations
US11298316B2 (en) Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US20200206264A1 (en) Methods of treatment using topical copper ion formulations
AU2017326244B2 (en) Methods of treatment using topical copper ion formulations
US20220226235A1 (en) Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
CA3184333A1 (fr) Compositions d'ions cuivre et methodes de traitement d'etats provoques par le coronavirus et la grippe
US20140271919A1 (en) Topical Copper Ion Treatments and Methods of Treatment Using Topical Copper Ion Treatments in the Genital-Rectal Areas of the Body
AU2020201265B2 (en) Methods of treatment using topical copper ion formulations